BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18330602)

  • 1. SHEF: a vHTS geometrical filter using coefficients of spherical harmonic molecular surfaces.
    Cai W; Xu J; Shao X; Leroux V; Beautrait A; Maigret B
    J Mol Model; 2008 May; 14(5):393-401. PubMed ID: 18330602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-ligand recognition using spherical harmonic molecular surfaces: towards a fast and efficient filter for large virtual throughput screening.
    Cai W; Shao X; Maigret B
    J Mol Graph Model; 2002 Jan; 20(4):313-28. PubMed ID: 11858640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fast surface-matching procedure for protein-ligand docking.
    Yamagishi ME; Martins NF; Neshich G; Cai W; Shao X; Beautrait A; Maigret B
    J Mol Model; 2006 Sep; 12(6):965-72. PubMed ID: 16673083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HierVLS hierarchical docking protocol for virtual ligand screening of large-molecule databases.
    Floriano WB; Vaidehi N; Zamanakos G; Goddard WA
    J Med Chem; 2004 Jan; 47(1):56-71. PubMed ID: 14695820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using consensus-shape clustering to identify promiscuous ligands and protein targets and to choose the right query for shape-based virtual screening.
    Pérez-Nueno VI; Ritchie DW
    J Chem Inf Model; 2011 Jun; 51(6):1233-48. PubMed ID: 21604699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient method for high-throughput virtual screening based on flexible docking: discovery of novel acetylcholinesterase inhibitors.
    Mizutani MY; Itai A
    J Med Chem; 2004 Sep; 47(20):4818-28. PubMed ID: 15369385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for the prediction of protein-ligand binding sites for structure-based drug design and virtual ligand screening.
    Laurie AT; Jackson RM
    Curr Protein Pept Sci; 2006 Oct; 7(5):395-406. PubMed ID: 17073692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel technologies for virtual screening.
    Lengauer T; Lemmen C; Rarey M; Zimmermann M
    Drug Discov Today; 2004 Jan; 9(1):27-34. PubMed ID: 14761803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward high throughput 3D virtual screening using spherical harmonic surface representations.
    Mavridis L; Hudson BD; Ritchie DW
    J Chem Inf Model; 2007; 47(5):1787-96. PubMed ID: 17824600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico fragment screening by replica generation (FSRG) method for fragment-based drug design.
    Fukunishi Y; Mashimo T; Orita M; Ohno K; Nakamura H
    J Chem Inf Model; 2009 Apr; 49(4):925-33. PubMed ID: 19354203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtual Ligand Screening Using PL-PatchSurfer2, a Molecular Surface-Based Protein-Ligand Docking Method.
    Shin WH; Kihara D
    Methods Mol Biol; 2018; 1762():105-121. PubMed ID: 29594770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel HIV entry inhibitors for the CXCR4 receptor by prospective virtual screening.
    Pérez-Nueno VI; Pettersson S; Ritchie DW; Borrell JI; Teixidó J
    J Chem Inf Model; 2009 Apr; 49(4):810-23. PubMed ID: 19358515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Database screening for HIV protease ligands: the influence of binding-site conformation and representation on ligand selectivity.
    Schnecke V; Kuhn LA
    Proc Int Conf Intell Syst Mol Biol; 1999; ():242-51. PubMed ID: 10786307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ontology for pharmaceutical ligands and its application for in silico screening and library design.
    Schuffenhauer A; Zimmermann J; Stoop R; van der Vyver JJ; Lecchini S; Jacoby E
    J Chem Inf Comput Sci; 2002; 42(4):947-55. PubMed ID: 12132896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure based drug design for HIV protease: from molecular modeling to cheminformatics.
    Volarath P; Harrison RW; Weber IT
    Curr Top Med Chem; 2007; 7(10):1030-8. PubMed ID: 17508936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel 2D fingerprints for ligand-based virtual screening.
    Ewing T; Baber JC; Feher M
    J Chem Inf Model; 2006; 46(6):2423-31. PubMed ID: 17125184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient molecular docking of NMR structures: application to HIV-1 protease.
    Huang SY; Zou X
    Protein Sci; 2007 Jan; 16(1):43-51. PubMed ID: 17123961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Countering cooperative effects in protease inhibitors using constrained beta-strand-mimicking templates in focused combinatorial libraries.
    Reid RC; Pattenden LK; Tyndall JD; Martin JL; Walsh T; Fairlie DP
    J Med Chem; 2004 Mar; 47(7):1641-51. PubMed ID: 15027855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A method for including protein flexibility in protein-ligand docking: improving tools for database mining and virtual screening.
    Broughton HB
    J Mol Graph Model; 2000 Jun; 18(3):247-57, 302-4. PubMed ID: 11021541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pseudo-ligand approach to virtual screening.
    Schüller A; Fechner U; Renner S; Franke L; Weber L; Schneider G
    Comb Chem High Throughput Screen; 2006 Jun; 9(5):359-64. PubMed ID: 16787149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.